Anti-tumor immunity enhancement by photodynamic therapy with talaporfin sodium and anti-programmed death 1 antibodyMakiko Sasaki, Hiromi Kataoka|Molecular Therapy — Oncolytics|2023Cited by 29
The neutrophil‐to‐lymphocyte ratio at the start of the second course during atezolizumab plus bevacizumab therapy predicts therapeutic efficacy in patients with advanced hepatocellular carcinoma: A multicenter analysisSho Matoya, Hiromu Kondo, Yoshihide Kimura et al.|Hepatology Research|2023Cited by 22
Urolithin A targets the AKT/WNK1 axis to induce autophagy and exert anti-tumor effects in cholangiocarcinomaHidenori Sahashi, Hiromi Kataoka|Frontiers in Oncology|2022Cited by 17
Relevance of gene mutations and methylation to the growth of pancreatic intraductal papillary mucinous neoplasms based on pyrosequencingGo Asano, Hiromi Kataoka|Scientific Reports|2022Cited by 10
Reovirus combined with a STING agonist enhances anti-tumor immunity in a mouse model of colorectal cancerNaomi Sugimura, Hiromi Kataoka|Cancer Immunology Immunotherapy|2023Cited by 8